XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating Expenses:    
Research and development $ 4,008,896 $ 2,094,095
General and administrative 1,942,763 1,337,649
Total Operating Expenses 5,951,659 3,431,744
Loss From Operations (5,951,659) (3,431,744)
Other Income:    
Interest income 19,275 2,137
Net Loss $ (5,932,384) $ (3,429,607)
Net Loss Per Share    
- Basic and Diluted $ (0.50) $ (0.45)
Weighted Average Number of Common Shares Outstanding    
- Basic and Diluted 11,919,973 7,561,915